Teresa Rummans is a Psychiatry physician. OpenAlex indexes 280 publications with 15,915 citations (h-index 64); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 20 Aug 2020.
Clinical trials
- Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder
Sponsor: National Institute of Mental Health (NIMH)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Other antidepressants29.6%Mirtazapine100%Part D<11 patientsAtypical Antipsychotic25.9%Quetiapine Fumarate100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1997–2003 per NIH RePORTER. The latest:
- Continuation ECT vs Pharmacotherapy: Efficacy &Safety
Mayo Clinic Coll of Medicine, Rochester
FY2003$278,345R01MH055484 - Continuation ECT vs Pharmacotherapy: Efficacy &Safety
Mayo Clinic Coll of Medicine, Rochester
FY2002$274,159R01MH055484 - CONTINUATION ECT VS PHARMACOTHERAPY--EFFICACY AND SAFETY
Mayo Clinic Coll of Medicine, Rochester
FY2001$273,962R10MH055484
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Infectious diseases occurring in the context of substance use disorders: A concise review
Journal of the Neurological Sciences
2020 - The effects of parental opioid use on the parent–child relationship and children’s developmental and behavioral outcomes: a systematic review of published reports
Child and Adolescent Psychiatry and Mental Health
2019 - Evidence for telehealth group-based treatment: A systematic review
Journal of Telemedicine and Telecare
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”